Understanding Stomach Ulcers: Causes, Types, and the Microbiome Connection

A peptic ulcer is an open sore in the lining of the stomach (gastric ulcer) or upper portion of the small intestine (duodenal ulcer). The mucosal barrier — a protective layer of mucus, bicarbonate, and epithelial cells — normally shields the stomach wall from gastric acid. When this barrier breaks down, stomach acid and the enzyme pepsin erode the underlying tissue, creating ulcers that range from mildly uncomfortable to seriously debilitating.

The Two Primary Causes

Helicobacter pylori infection accounts for approximately 70–90% of duodenal ulcers and 60–70% of gastric ulcers. H. pylori is a Gram-negative bacterium uniquely adapted to survive the acidic environment of the stomach by producing urease, an enzyme that neutralizes gastric acid and enables colonization of the mucosal layer. Once established, H. pylori triggers chronic gastric inflammation, progressively damaging the mucosal barrier and increasing the risk of ulcer formation, and — in severe or untreated cases — gastric cancer.^[6]

NSAID use (nonsteroidal anti-inflammatory drugs like ibuprofen, aspirin, and naproxen) is the second major cause. NSAIDs inhibit COX-1, an enzyme responsible for producing prostaglandins that maintain the protective mucosal lining. Without adequate prostaglandin activity, the mucosal barrier thins and becomes vulnerable to acid erosion. Chronic NSAID users face significantly elevated ulcer risk, which is compounded when H. pylori infection is also present.

The clinical picture is complicated further by the fact that most people with H. pylori remain asymptomatic for years or decades. The infection is slow-burning, progressive, and widespread — current estimates place H. pylori prevalence at approximately 4.4 billion people globally.^[6] For those who do develop ulcers, the standard antibiotic regimen works — but achieving eradication rates consistently above 90% remains an ongoing challenge due to antibiotic resistance and patient-side effects.

How Probiotics Support Gastric Ulcer Management

The mechanisms by which probiotics influence gastric ulcer outcomes are multiple, and the research distinguishes between their roles in active H. pylori eradication versus their broader effects on mucosal repair and barrier maintenance.

Competing with H. pylori for Adhesion Sites

H. pylori's ability to colonize the stomach depends on its adherence to gastric epithelial cells. Probiotics — particularly Lactobacillus species — compete directly with H. pylori for these adhesion sites. By binding to gastric epithelium first, Lactobacillus strains physically block H. pylori from establishing the colonization that drives chronic inflammation. Research has confirmed that Lactobacillus fermentum, L. gasseri, L. acidophilus, and L. rhamnosus all demonstrate competitive exclusion activity against H. pylori in vitro and in animal models.^[7]

Producing Antimicrobial Metabolites

Lactobacillus species produce lactic acid, bacteriocins, and hydrogen peroxide — metabolites with direct inhibitory activity against H. pylori. The mechanism for L. gasseri has been particularly well-characterized: this strain produces dl-lactic acid that induces coccoid conversion of H. pylori (transforming it into a dormant, non-pathogenic form) and inhibits its multiplication.^[3] This makes L. gasseri's mechanism of action against H. pylori distinctly different from — and complementary to — the mechanism of antibiotic therapy.

Enhancing Mucosal Barrier Integrity

The gastric mucosal barrier relies on tight junction proteins, mucus secretion, and adequate blood flow. Probiotic strains, particularly Lactobacillus rhamnosus, L. plantarum, and Bifidobacterium species, have been demonstrated to upregulate tight junction protein expression, stimulate mucin production, and promote prostaglandin E2 synthesis — a key mediator of mucosal protection.^[8] These effects are relevant both for active ulcer healing and for prophylactic protection against NSAID-induced mucosal injury.

Reducing Pro-inflammatory Cytokines

H. pylori infection activates NF-κB, triggering the release of pro-inflammatory cytokines including IL-8 and TNF-α in gastric epithelial cells. Probiotic supplementation has been shown to dampen this inflammatory cascade, reducing cytokine production and moderating the inflammatory damage that drives ulcer progression.^[7] In the VSL#3 gastric ulcer healing study, probiotic treatment significantly reduced gene expression of multiple pro-inflammatory cytokines while simultaneously upregulating the regulatory cytokine IL-10 and mucin MUC5AC.^[5]

Promoting Angiogenesis and Ulcer Healing

Healing of established gastric ulcers requires new blood vessel formation (angiogenesis), epithelial cell proliferation, and reconstruction of the mucosal architecture. Vascular endothelial growth factor (VEGF) is the primary driver of this regenerative process. Studies have shown that probiotic supplementation — particularly multi-strain formulas containing Lactobacillus and Bifidobacterium species — upregulates VEGF expression, stimulating granulation tissue formation and accelerating the ulcer healing timeline.^[5]

Best Probiotic Strains for Stomach Ulcers: What's in MicroBiome Restore

Not every probiotic strain has demonstrated gastric-specific activity. The following strains are those with the strongest documented evidence for stomach ulcer support — and all are present in MicroBiome Restore. Notably, Saccharomyces boulardii — while frequently studied in this context — is a yeast, not a bacterial probiotic, and is not included in this discussion.

Lactobacillus gasseri: Gastric Mucus Layer Colonization

Lactobacillus gasseri is arguably the most stomach-relevant probiotic strain studied to date. Unlike most probiotics, L. gasseri possesses unusually strong acid resistance — a property identified after screening over 200 Lactobacillus strains. Critically, research has demonstrated that L. gasseri OLL2716 can actually colonize the gastric mucus layer in humans, positioning it directly at the site of H. pylori activity.^[3]

In a randomized controlled trial of 229 patients, pretreatment with L. gasseri OLL2716-containing yogurt prior to first-line triple therapy resulted in improved eradication rates compared to triple therapy alone.^[10] A subsequent multicenter double-blind RCT found that L. gasseri supplementation significantly reduced postprandial fullness and bloating in H. pylori-infected patients — symptom improvements that tracked with reduced H. pylori activity.^[11] The mechanism involves dl-lactic acid-mediated coccoid conversion of H. pylori, effectively neutralizing the pathogen's proliferative capacity.^[3]

Explore the broader clinical evidence for Lactobacillus gasseri beyond its gastric applications.

Lactobacillus acidophilus: Mucosal Adhesion and Barrier Defense

Lactobacillus acidophilus has been identified in clinical research as one of the probiotic strains best able to survive gastric acid and adhere to the gastric mucosa — properties essential for exerting local therapeutic effects in the stomach. Studies confirm that L. acidophilus survives at pH ≥3 after extended incubation, making it resilient in the harsh gastric environment where ulcers form.^[8]

In animal models, L. acidophilus supplementation — both alone and in combination with other strains — demonstrated the ability to restore normal biochemical, physiological, and histological parameters in induced gastric ulcer models. When encapsulated in alginate and combined with ginger extract, L. acidophilus significantly promoted ulcer healing in stress-induced gastric injury models by restoring mucosal architecture.^[8] In vitro research using stomach-isolated L. acidophilus strains confirmed significant anti-H. pylori activity and reduction of gastric mucosal inflammation.^[12]

Lactobacillus rhamnosus: Epithelial Regeneration and Prostaglandin Support

Lactobacillus rhamnosus GG has been studied extensively in gastric ulcer models for its ability to increase the cellular proliferation-to-apoptosis ratio at ulcer margins, actively driving epithelial cell regeneration. Research demonstrates that L. rhamnosus GG upregulates prostaglandin E2 and mucus secretion, strengthens transmural resistance, and protects against ethanol-induced gastric mucosal lesions.^[8] These effects work synergistically with antibiotic therapy by preserving and rebuilding the mucosal architecture that H. pylori has eroded.

Beyond ulcer healing, Lactobacillus rhamnosus is one of the most well-characterized probiotic strains for overall gastrointestinal health, with a body of evidence spanning hundreds of clinical trials across multiple indications.

Lactobacillus casei and Lactobacillus plantarum: Multi-Mechanism Support

Both L. casei and L. plantarum are components of the VSL#3 multi-strain formula that accelerated gastric ulcer healing in dose-dependent fashion in published animal research. VSL#3's composition specifically includes L. casei, L. acidophilus, L. bulgaricus, L. plantarum, Bifidobacterium breve, B. infantis, B. longum, and Streptococcus thermophilus — every one of these strains is present in MicroBiome Restore.^[5]

L. plantarum in particular is noted for its robust capacity to support intestinal barrier integrity, with research demonstrating upregulation of tight junction proteins and mucin production. These barrier-reinforcing properties are directly relevant to ulcer management, where permeability of the gastric lining is the fundamental pathological mechanism. For a deeper look at the clinical research, see our article on Lactobacillus plantarum health benefits.

Bifidobacterium Species: Immune Modulation and Barrier Repair

The Bifidobacterium species in MicroBiome Restore — including B. bifidum, B. breve, B. infantis, B. lactis, and B. longum — contribute to ulcer management primarily through immune modulation, anti-inflammatory activity, and barrier repair. Research has demonstrated that Bifidobacterium species reduce pro-inflammatory cytokine production, enhance mucosal IgA, and contribute to the microbiome-based competitive exclusion of H. pylori.^[7]

Specifically, B. bifidum polysaccharide fractions have been shown to repair and protect gastric mucosa, while B. bifidum and B. breve combinations demonstrate mucosal barrier protection in gastric ulcer models.^[8] B. longum, meanwhile, shows particularly strong adherence to the gastric mucosa among Bifidobacterium species, positioning it for local anti-inflammatory effects at the ulcer site. For more on the clinical significance of adequate Bifidobacterium populations, see our article on Bifidobacterium deficiency.

Lactobacillus fermentum: Direct Anti-H. pylori Activity

Lactobacillus fermentum isolated from human gastric mucosa has been studied for its direct antagonistic activity against H. pylori. In a mouse model of H. pylori-associated gastritis, stomach-derived L. fermentum strains demonstrated efficacy approaching that of standard triple antibiotic therapy — significantly alleviating gastric mucosal inflammation in the gastric antrum and body.^[12] These findings reinforce the relevance of gastric-origin Lactobacillus strains for upper GI applications.

Probiotics and H. pylori Eradication: The Clinical Evidence

The body of evidence on probiotics as adjuncts to H. pylori eradication therapy is now substantial — and the direction is consistently positive, even if effect sizes vary across studies.

Umbrella Review: 28 Meta-Analyses, 534 RCTs

A 2024 umbrella review published in Scientific Reports, the most comprehensive synthesis of this literature to date, pooled data from 28 unique meta-analyses based on 534 RCTs. The conclusions were clear: probiotic supplementation was significantly associated with improved H. pylori eradication rates (RR 1.10, 95% CI 1.06–1.14) and meaningfully reduced total treatment side effects — particularly antibiotic-associated diarrhea, the most common reason for non-compliance with eradication regimens.^[2]

Multi-Strain Probiotics Outperform Single Strains

A 2025 meta-analysis evaluating probiotics as adjuncts to bismuth quadruple therapy found that multi-strain probiotic formulations significantly enhanced eradication rates with an odds ratio of 1.66 (p < 0.05) — a stronger effect than single-strain formulas.^[4] This finding aligns with the broader principle that diverse microbial communities provide broader competitive coverage against H. pylori across multiple sites, mechanisms, and lactic acid types.

Pretreatment with Probiotics Boosts Eradication

An interesting subquestion in this literature is whether timing of probiotic use relative to antibiotic therapy matters. A 2024 systematic review and meta-analysis examining probiotics used before H. pylori eradication therapy — across 12 RCTs with 2,144 participants — found that probiotic pretreatment significantly improved eradication rates versus no pretreatment, with the effect persisting across both intention-to-treat and per-protocol analyses.^[9] The implication: establishing a robust probiotic community before introducing antibiotics may reduce competitive disruption and improve outcomes.

A Note on Realistic Expectations

The evidence strongly supports probiotics as adjuncts — supplements to, not replacements for — standard H. pylori eradication therapy. Probiotic monotherapy has not been shown to consistently eradicate H. pylori. Even well-studied strains like L. gasseri show H. pylori suppression (reduced bacterial density, reduced inflammation) rather than full eradication when used alone. What probiotics do very well is improve the efficacy and tolerability of conventional therapy — which, given that the compliance problem is one of the primary drivers of treatment failure, is clinically significant. Anyone with a confirmed H. pylori infection or active ulcer should work with a healthcare provider for appropriate diagnosis and treatment.

What to Look for in a Probiotic for Gastric Health

If you're supporting gastric health or recovering from antibiotic therapy, not all probiotics are created equal. The gastric environment is uniquely harsh — and the criteria for an effective gastric-health probiotic go beyond the general-purpose considerations that apply to digestive wellness broadly.

Acid-Resistant Strains

The first requirement for any probiotic aimed at gastric health is acid resistance. Strains must be able to survive the low pH of the stomach to exert any local effect. Clinical research specifically identifies L. gasseri, L. acidophilus, L. rhamnosus, and B. longum as strains with superior gastric acid tolerance compared to other species.^[8] L. acidophilus survives at pH ≥3, and L. rhamnosus demonstrates viability even at pH 2.5 — conditions that eliminate many common probiotic strains. This is one reason that strain selection matters far more than total CFU count alone.

Multi-Strain Diversity

The clinical evidence consistently favors multi-strain formulations for both H. pylori eradication support and mucosal healing. A formula that includes multiple Lactobacillus species alongside Bifidobacterium species provides broader mechanisms: competitive exclusion at multiple adhesion sites, different lactic acid profiles, diverse antimicrobial peptide production, and complementary effects on mucosal barrier components. The VSL#3 research — demonstrating dose-dependent gastric ulcer healing — used 8 strains. Multi-strain probiotics offer broader coverage that single-strain products simply cannot match.

Clean Formulation: Fillers That Hurt Rather Than Help

For someone managing a compromised gastric mucosal barrier, the formulation ingredients matter beyond the active probiotics. Microcrystalline cellulose (MCC), one of the most common filler ingredients in probiotic supplements, has been associated with effects on gut epithelial cells that are counterproductive for mucosal healing. Magnesium stearate and similar flow agents also have documented effects on gut permeability. For someone managing active ulcer disease or recovering from antibiotic-associated dysbiosis, these additives represent unnecessary variables.

Understanding how to read probiotic supplement labels for hidden fillers is a practical skill that pays dividends when selecting any gut health supplement. Capsule material matters too — pullulan capsules offer delayed-release protection and are derived from fermentation rather than synthetic sources, making them preferable for sensitive GI environments.

Prebiotic Support

Prebiotics — the non-digestible fibers that feed probiotic bacteria — enhance colonization efficiency and amplify the benefits of the probiotic strains themselves. For gastric health applications, prebiotic support helps establish and sustain the beneficial bacterial populations that compete with H. pylori and support mucosal repair. MicroBiome Restore includes seven certified organic prebiotics: Jerusalem artichoke, maitake mushroom, fig fruit, bladderwrack, Norwegian kelp, oarweed, and acacia gum — none of which are common filler prebiotics, and all of which support the growth of the Lactobacillus and Bifidobacterium species most relevant to gastric health.

Frequently Asked Questions

Supporting Your Gastric Health With Evidence-Based Probiotics

The clinical picture for probiotics in gastric ulcer management has clarified substantially over the past decade. The evidence supports a nuanced but actionable conclusion: specific probiotic strains — particularly L. gasseri, L. acidophilus, L. rhamnosus, L. casei, L. plantarum, and Bifidobacterium species — provide meaningful support for H. pylori eradication therapy, mucosal barrier repair, and recovery from antibiotic-associated microbiome disruption. Multi-strain formulations consistently outperform single-strain approaches.

What matters most is choosing a probiotic with the right strains for gastric applications, the formulation quality to survive transit and actually reach the mucosa, and the prebiotic support to sustain colonization. A probiotic loaded with effective strains but undermined by fillers and flow agents is a contradiction in terms — particularly for someone managing compromised mucosal tissue.

Explore our complete guide to MicroBiome Restore to understand how our 26-strain, filler-free formula was built around the principle that every ingredient should earn its place.